• Optimizing Cancer Assays with Everolimus (RAD001): Real Lab

  2026-07-20

  This article provides a scenario-driven roadmap for bench scientists using Everolimus (RAD001) (SKU A8169) to address key challenges in cell viability, proliferation, and cytotoxicity assays. Integrating cross-validated protocol guidance, comparative analysis, and evidence-backed insights, it demonstrates how Everolimus ensures reproducible, reliable data in cancer biology research workflows.

• Cy5 NHS ester(Et): Technical Guidance for Protein Labeling

  2026-07-20

  Cy5 NHS ester(Et) addresses the need for efficient, water-soluble fluorescent labeling of primary amines in proteins, peptides, and related biomolecules. It is best suited for immediate-use workflows in immunofluorescence, flow cytometry, and microscopy, but is not compatible with ethanol-based protocols or long-term storage of dye solutions.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-07-19

  This study reveals how the WNT5a/GSK3/β-catenin signaling axis critically controls the adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, cytometric, and transcriptomic methods, the authors identify strategies to restrain pathological fat infiltration in muscle disorders, offering new directions for myopathy research.

• Structural Insights and Neurophysiological Impact of ω-Agato

  2026-07-18

  Discover how ω-Agatoxin IVA TFA illuminates Cav2.1 channel function through unique structure-activity relationships, advancing both synaptic transmission research and epilepsy model design. This article unpacks the mechanistic depth and translational outlook that set this reagent apart.

• Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein La

  2026-07-17

  Cy7 NHS ester is a sulfonated, hydrophilic near-infrared dye designed for robust labeling of proteins and peptides via amino groups, minimizing quenching and denaturation. It is best suited for workflows requiring water solubility and live or in vivo imaging, but is not ideal for targets lacking primary amines or for experiments needing long-term dye stability in solution.

• Strategic mRNA Synthesis for FLCN Rescue in BHD Syndrome

  2026-07-17

  Translational researchers face new opportunities in rare disease intervention thanks to mechanistic advances in mRNA-based therapies. This article frames the strategic use of high-yield T7-driven RNA synthesis—anchored by the HyperScribe™ T7 High Yield RNA Synthesis Kit Plus—in enabling functional FLCN mRNA rescue for Birt-Hogg-Dubé (BHD) syndrome, bridging genetic insights and translational workflow design. By synthesizing evidence from recent studies, we outline how optimized in vitro transcription protocols can accelerate therapeutic innovation, benchmark kit selection, and define the future of precision mRNA platforms for rare disease applications.

• miR-146a/b-5p–IRAK1–NF-κB Axis in Unexplained Recurrent Abor

  2026-07-16

  The reference study identifies the miR-146a/b-5p–IRAK1–NF-κB pathway as a critical regulator of unexplained recurrent spontaneous abortion (URSA). By integrating transcriptomic analyses with in vitro and in vivo experiments, the authors provide mechanistic evidence linking trophoblast dysfunction and inflammatory imbalance to URSA, highlighting miR-146a/b-5p as a potential therapeutic target.

• LPS-Mediated Macrophage Protection via System Xc− and ABCC1

  2026-07-16

  This study reveals that lipopolysaccharide (LPS) shields macrophages from antitumor drug toxicity by upregulating the cystine/glutamate antiporter system Xc− and engaging ABCC1-mediated drug transport. These insights clarify how immune cells can be selectively protected during chemotherapy, offering targeted strategies to reduce collateral toxicity.

• Ganoderma Polysaccharide Boosts mRNA-LNP Efficacy via Redox

  2026-07-15

  This study demonstrates that Ganoderma lucidum polysaccharide (GLP) acts as a novel adjuvant in mRNA-lipid nanoparticle (LNP) systems, significantly enhancing transfection efficiency by mitigating LNP-induced oxidative stress. The findings have important implications for advancing mRNA delivery strategies and improving the safety and potency of mRNA-based vaccines.

• Protease and Phosphatase Inhibitor Cocktail: Optimizing Prot

  2026-07-15

  Unlock robust protein extraction and phosphorylation state preservation with APExBIO’s Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This article translates cutting-edge reference research into actionable workflows and troubleshooting strategies for advanced cell signaling and proteomics.

• LPS Protects Macrophages from Chemotherapy via System Xc− an

  2026-07-14

  This study reveals that lipopolysaccharide (LPS) shields macrophages from antitumor drug-induced cytotoxicity by upregulating system Xc− and involving ABCC1-mediated transport. The findings highlight new molecular targets for selectively protecting immune cells during chemotherapy, with potential relevance for designing less toxic cancer treatments.

• Lopinavir (ABT-378): Optimizing HIV Protease and Viral Assay

  2026-07-14

  Lopinavir (ABT-378) stands out as a robust, serum-stable HIV protease inhibitor with proven efficacy in both HIV and emergent coronavirus research. This guide translates quantitative findings and the latest cross-domain breakthroughs into practical protocols, troubleshooting strategies, and workflow enhancements for antiviral assay development.

• Lamotrigine: Applied Protocols and Troubleshooting in CNS &

  2026-07-13

  Lamotrigine unlocks high-precision sodium channel and serotonin pathway modulation for epilepsy and cardiac arrhythmia research. This in-depth guide details robust workflows, key troubleshooting steps, and actionable insights, drawing on cutting-edge reference data and comparative studies to maximize research reproducibility.

• Evaluating Fumagillin and Antiprotozoals for Soft Tunic Synd

  2026-07-13

  This reference study systematically tested antiprotozoal agents, including Fumagillin—a known methionine aminopeptidase-2 inhibitor—against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings clarify both the in vitro and in vivo efficacy profiles of candidate drugs, informing future aquaculture disease management and translational research.

• QRICH1 Drives HBV-Mediated HMGB1 Secretion in Hepatic Fibros

  2026-07-12

  This study uncovers QRICH1 as a crucial mediator linking endoplasmic reticulum (ER) stress to HBV-driven HMGB1 translocation and secretion in hepatocytes. The findings illuminate a mechanistic axis underlying hepatic fibrosis progression, with implications for targeting QRICH1 in future liver disease research.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page